Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Ritlecitinib is safe and may effectively treat alopecia areata.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.